IRIS
BERNARDINI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.646
EU - Europa 9.779
AS - Asia 4.643
SA - Sud America 727
Continente sconosciuto - Info sul continente non disponibili 310
AF - Africa 248
OC - Oceania 19
Totale 28.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.471
GB - Regno Unito 2.411
IT - Italia 1.820
RU - Federazione Russa 1.621
CN - Cina 1.555
SG - Singapore 1.430
IE - Irlanda 1.016
DE - Germania 629
BR - Brasile 621
SE - Svezia 592
UA - Ucraina 567
VN - Vietnam 507
FR - Francia 491
HK - Hong Kong 323
FI - Finlandia 236
KR - Corea 224
IN - India 150
TR - Turchia 104
ZA - Sudafrica 95
CA - Canada 85
ES - Italia 78
BD - Bangladesh 72
NL - Olanda 66
CI - Costa d'Avorio 56
MX - Messico 47
BE - Belgio 46
PL - Polonia 45
AR - Argentina 44
NG - Nigeria 41
CZ - Repubblica Ceca 39
JP - Giappone 36
IQ - Iraq 33
AT - Austria 32
PK - Pakistan 31
ID - Indonesia 29
IR - Iran 23
UZ - Uzbekistan 16
JO - Giordania 14
PT - Portogallo 14
AE - Emirati Arabi Uniti 13
AU - Australia 12
AZ - Azerbaigian 12
CO - Colombia 12
EC - Ecuador 12
KE - Kenya 12
LT - Lituania 12
TN - Tunisia 11
CR - Costa Rica 10
MA - Marocco 10
VE - Venezuela 10
BO - Bolivia 9
CH - Svizzera 9
EE - Estonia 9
EG - Egitto 9
MY - Malesia 9
RO - Romania 9
SA - Arabia Saudita 9
EU - Europa 8
PE - Perù 8
AM - Armenia 6
JM - Giamaica 6
NZ - Nuova Zelanda 6
CL - Cile 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
NO - Norvegia 5
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
ET - Etiopia 4
IL - Israele 4
KZ - Kazakistan 4
PA - Panama 4
PR - Porto Rico 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
BY - Bielorussia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
PH - Filippine 3
RS - Serbia 3
AL - Albania 2
DK - Danimarca 2
DZ - Algeria 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
MT - Malta 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
TH - Thailandia 2
TZ - Tanzania 2
UG - Uganda 2
UY - Uruguay 2
Totale 28.053
Salva come PNG Salva come JPEG
Città #
Southend 2.135
Dallas 1.420
Fairfield 1.176
Menlo Park 1.053
Dublin 1.002
Ashburn 865
Singapore 847
Chandler 663
Woodbridge 526
Santa Clara 474
Jacksonville 467
Milan 451
Moscow 442
Siena 430
San Jose 417
Wilmington 412
Seattle 407
Houston 393
Cambridge 391
Beijing 349
Ann Arbor 317
Hong Kong 307
Council Bluffs 295
Hefei 257
Seoul 218
Princeton 206
Los Angeles 165
Nanjing 158
New York 153
Ho Chi Minh City 150
The Dalles 142
Helsinki 126
Rome 117
Boardman 100
Hanoi 100
Lauterbourg 99
Florence 86
Johannesburg 84
Munich 83
Izmir 74
Columbus 70
San Mateo 70
Dearborn 69
Shanghai 67
San Diego 64
Buffalo 58
São Paulo 58
Abidjan 56
Nanchang 54
Lancaster 49
Bengaluru 47
Orem 45
Brussels 44
Dong Ket 44
London 43
Shenyang 42
Abuja 40
Warsaw 40
Fremont 39
Málaga 38
Frankfurt am Main 35
Tianjin 33
Changsha 31
Haiphong 30
Da Nang 29
Figino 29
Stockholm 29
Hebei 28
Redwood City 28
Phoenix 27
Chicago 26
Redondo Beach 25
Rio de Janeiro 25
Tokyo 24
Toronto 24
Atlanta 23
Boston 23
Brno 23
Brooklyn 23
Denver 23
Kunming 22
Vienna 22
Jinan 21
Mexico City 19
Poplar 19
Turin 19
Turku 19
Jiaxing 18
Belo Horizonte 17
Hangzhou 17
Jakarta 17
Manchester 17
Montreal 17
Zhengzhou 17
Amsterdam 16
San Francisco 16
Washington 16
Monteroni D'arbia 15
Mumbai 15
Ningbo 15
Totale 19.486
Salva come PNG Salva come JPEG
Nome #
Chondroptosis in alkaptonuric cartilage 493
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 492
Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient 429
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases 417
Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria 412
Biochemical and proteomic characterization of alkaptonuric chondrocytes 400
Novel smoothened antagonists as anti-neoplastic agents for the treatment of osteosarcoma 387
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 384
CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration 379
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 378
Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: preliminary in vitro studies with analogues of immucillin-G 375
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria 370
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies 364
Beer promotes differentiation and mineralization of human osteoblastic cells: Role of silicon 362
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 359
Alkaptonuria is a novel human secondary amyloidogenic disease 355
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project 353
Angiogenesis in alkaptonuria 350
Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis 332
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 318
A proteomic study of human osteoblastic cells proliferation and differentiation 315
Diagnosis of secondary amyloidosis in alkaptonuria 313
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. 309
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure 309
Toward a generalized computational workflow for exploiting transient pockets as new targets for small molecule stabilizers: Application to the homogentisate 1,2-dioxygenase mutants at the base of rare disease Alkaptonuria 307
Application of proteomics to the study of Helicobacter pylori and implications for the clinic 306
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 303
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 298
Quick Diagnosis of Alkaptonuria by Homogentisic Acid Determination in Urine Paper Spots 295
A new light on Alkaptonuria: A Fourier-transform infrared microscopy (FTIRM) and low energy X-ray fluorescence (LEXRF) microscopy correlative study on a rare disease 295
Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins 294
Proteomic investigation of dermal fibroblasts isolated from affected and unaffected skin samples from patients with limited cutaneous systemic sclerosis: 2 distinct entities? 294
Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria 291
Amyloidosis in alkaptonuria 290
Wild-type wine Saccharomyces cerevisiae as a tool to evaluate the effects on eukaryotic life of locally used herbicides 287
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes 287
Modern proteomic methodologies for the characterization of lactosylation protein targets in milk 284
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease 283
Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease 279
Secondary amyloidosis in an alkaptonuric aortic valve 276
Differentially activated Src kinase in chemo-naive human primary osteosarcoma cells and effects of a Src kinase inhibitor 274
Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria 273
Antimicrobial efficacy of five probiotic strains against Helicobacter pylori 272
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis 272
Conformations and biological activities of Amyloid Beta Peptide 25-35 268
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria 268
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis 268
Antibacterial activity of grape extracts towards cagA positive and cagA negative Helicobacter pylori clinical isolates 267
Oxidative stress and mechanisms of ochronosis in alkaptonuria 264
Saccharomyces cerevisiae as a Tool to Evaluate the Effects of Herbicides on Eukaryotic Life 262
Mapping phosphoproteins in Neisseria meningitidis serogroup A 261
Padina pavonica Extract Promotes In Vitro Differentiation and Functionality of Human Primary Osteoblasts 260
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells. 258
Helicobacter pylori infection and autoimmune thyroid diseases: The role of virulent strains 258
Pro-Apoptotic activity of French Polynesian Padina pavonica Extract on Human Osteosarcoma Cells 254
Helicobacter pylori: immunoproteomics related to different pathologies 252
Oxidative damage mediated by herbicides on yeast cells 251
Animal and cell models for Lesch-Nyhan syndrome 251
Alkaptonuria 250
Inactivation of Helicobacter pylori cagA gene affects motility 248
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain 244
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure 242
Foodomics for human health: current status and perspectives 240
Homogentisic acid affects human osteoblastic functionality by oxidative stress and alteration of the Wnt/β-catenin signaling pathway 240
Proteomics of osteosarcoma 232
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model 231
Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer 228
TREATMENT OF ALKAPTONURIA AND TYROSINEMIA TYPE 1 227
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria 218
Metodologia dell’elettroforesi bidimensionale 217
Oxidative damage induced by herbicides is mediated by thiol oxidation and hydroperoxides production 214
Proteomics and phosphoproteomics provide insights into the mechanism of action of a novel pyrazolo[3,4-d]pyrimidine Src inhibitor in human osteosarcoma 214
Post-genomics of bone metabolic dysfunctions and neoplasias 211
Expanding the proteome database of Meningococcus A 203
Saccharomyces cerevisiae as a model in ecotoxicological studies: a post-genomics perspective 201
Treatment of alkaptonuria and tyrosinemia type I 200
Identification of new epidemiological molecular markers by comparative proteomics of serogroup A meningococcal isolates from three pandemic waves 199
Postgenomics of Neisseria meningitidis: An update 197
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice 194
Tumor-associated macrophages in Osteosarcoma: from mechanisms to therapy 194
Surfome analysis of a wild-type wine Saccharomyces cerevisiae strain 193
Bacterial post-genomics approaches for vaccines development 192
Linking protein oxidation to environmental pollutants: redox proteomic approaches 183
Western blotting on total lysate of Helicobacter pylori 182
Omics and rare diseases: challenges, applications, and future perspectives 179
Post-genomics and skin inflammation 178
The therapy for Helicobacter pylori eradication 176
Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies 174
Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype 171
Proteomics of metronidazole resistance in clinical isolates of Helicobacter pylori 165
Rubus ulmifolius Leaf Extract Inhibits Proliferation of Murine Myeloma Cells 164
Diagnosis of Helicobacter pylori infection 163
Leveraging proteomics in orphan disease research: pitfalls and potential 160
Proteome analysis of Neisseria meningitidis serogroup A 159
The analysis of Neisseria meningitidis proteomes: reference maps and their applications 156
Surface properties of nanocrystalline TiO2 coatings in relation to the in vitro plasma protein adsorption 154
Postgenomics of Neisseria meningitidis for vaccines development 153
Identification of Helicobacter pylori proteins involved in metronidazole resistance by comparative proteomic analysis 152
Inborn errors of purine salvage and catabolism 147
null 145
Totale 26.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.690 0 206 116 131 90 68 94 81 101 242 190 371
2022/20232.244 133 217 282 320 216 438 47 195 218 54 69 55
2023/20241.654 66 33 156 74 65 452 535 43 8 18 37 167
2024/20253.330 64 193 383 185 391 195 159 226 315 109 335 775
2025/20268.651 560 1.083 1.214 1.011 1.630 278 945 206 277 424 194 829
2026/2027542 357 185 0 0 0 0 0 0 0 0 0 0
Totale 28.372